Carregant...
GDNF is not required for catecholaminergic neuron survival in vivo
Glial cell line-derived neurotrophic factor (GDNF) has been tested in clinical trials to treat Parkinson’s disease with promising but variable results. Improvement of therapeutic effectiveness requires solid understanding of the physiological role of GDNF in the maintenance of the adult brain catech...
Guardat en:
| Publicat a: | Nat Neurosci |
|---|---|
| Autors principals: | , , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4878654/ https://ncbi.nlm.nih.gov/pubmed/25710828 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nn.3941 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|